Searched for
ONCOLOGY
Lord's Mark Industries outlines strategic expansion across global healthcare, advanced diagnostics & oncology; targets ₹1,550 Crore revenue in FY2027In a strategic shift, Lord's Mark Industries is set to launch an extensive healthcare expansion alongside a business demerger. This initiat...- Moderna, Merck breakthrough could usher in wave of cancer vaccinesMerck and Moderna's personalized cancer vaccine shows promise for melanoma patients. This new treatment trains the immune system to target ...
- BHU secures 6 major research grants under ICMR scheme for high-impact biomedical innovation in Uttar PradeshBanaras Hindu University's medical institute received significant funding for six research projects. These initiatives focus on crucial nat...
- Time to take some risk, but with guardrails? 5 small-cap stocks with an upside potential of up to 30%With oil prices going past $91 a barrel yet again, expect volatility to keep hitting the markets. The contradictory claims by the US and Ir...
- For investors with ability to ignore short-term volatility: 5 mid-cap stocks from different sectors with upside potential up to 19%Most of what impacts the market these days comes from outside the country: Oil price spikes, tariff threats, FII pull out. There is, howeve...
- 4baseCare expands cancer profiling panel with 2,206-gene Indiegene V2The new version comes five years after the company launched Indiegene in August 2021. The original panel, developed using genomic data from...
- ET Startup Awards 2026: Nominees for Top InnovatorThe award will recognise innovations that launch a business or give it a big boost. It should be an original idea that is core to the busin...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsLooking at what happens in the short term is important, as it does have an impact on stock prices. But also always keep an eye on the macro...
- Bengaluru-based startup leans on cancer-sniffing dogs and AI for early detectionBilly, Jessie and Banu are part of a team of beagles, labradors, Dutch shepherds and other dog breeds being trained by startup Dognosis to ...
- LifeCell International partners with Shraddha Diagnostics to expand advanced diagnostics across GujaratThe company said that the partnership will combine Shraddha Diagnostics' regional presence, clinician relationships and expertise in routin...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Does a sugar-rich diet make you more vulnerable to cancer? Stanford University study reveals the truth: ‘A high intake of added sugar adds…'Does high blood sugar make you more susceptible to cancer or lead to more aggressive growth of cancerous cells? An article published in Sta...
- Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenueGland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer...
- Manipal Health shares slide 6% on account of profit booking. What should investors do?Manipal Health Enterprises shares fell sharply on Thursday day after their strong market debut, triggering profit booking. Analysts remain ...
- KKR buys Medicover’s India hospitals businessGlobal investment firm KKR has acquired Medicover India's hospital business. Sources said the the transaction values the hospital chain at ...
- KKR to acquire Medicover India in $1.5 billion dealThe transaction includes a sale of 100% stake by existing shareholders, as well as a commitment to deploy fresh capital to fund its growth ...
- Manipal Health Enterprises shares list at 11% premium over IPO price on BSE, NSEManipal Health Enterprises shares debuted on Wednesday with an 11% premium. The IPO garnered strong demand, especially from institutional i...
- Japan's Takeda bets on dengue vax to reshape India playbookTakeda Pharmaceutical's new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027....
- ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyThe ET Health Conclave 2026 celebrated healthcare professionals and institutions. Leaders shared insights on healthcare infrastructure and ...
- Sakar Healthcare posts Rs 10-crore profit in Q1Sakar Healthcare announced a substantial net profit increase for the first quarter of 2026-27. The company's revenue from operations also s...
Load More
